Internal Medicine, Pulmonary Disease · Flushing, NY
NPI
1518954957
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
13710 Franklin Ave, #l-1
Flushing, NY, 11355
Phone (718) 359-0005
Medicare paid, 2024
$18K
226 services
Medicare patients, 2024
69
Average age 76
Drug cost, 2024
$5.0M
5,731 prescriptions
Company payments, 2024
$4,295
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kyungmee Kim was code 99213 (office e&m - established), 91 times for 45 patients. In total Kyungmee Kim billed 226 services in 14 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-01-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 91 | 45 | $70.04 | $6,373 |
| 99214 Office E&M - Established | Office | 59 | 37 | $107.32 | $6,332 |
| 94010 Pulmonary Function Testing | Office | 14 | 14 | $16.13 | $226 |
| 99203 Office E&M - New | Office | 11 | 11 | $63.74 | $701 |
By year: 2022 $29K for 394 services; 2023 $26K for 352 services; 2024 $18K for 226 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kyungmee Kim prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,038 prescriptions and refills. In total Kyungmee Kim wrote 5,731 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,038 | 1,074 | 174 | $21K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 991 | 1,005 | 173 | $643K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 545 | 563 | 83 | $357K |
| Montelukast Sodium Generic | 468 | 490 | 79 | $1,412 |
| Azithromycin Generic | 248 | 265 | 80 | $2,105 |
| Levofloxacin Generic | 230 | 230 | 138 | $1,248 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 206 | 221 | 33 | $106K |
| Ofev Nintedanib Esylate | 191 | 191 | 23 | $2.6M |
| Breo Ellipta Fluticasone/Vilanterol | 180 | 186 | 34 | $74K |
| Symbicort Budesonide/Formoterol Fumarate | 156 | 165 | 43 | $38K |
| Ethambutol Hcl Generic | 136 | 148 | 20 | $3,268 |
| Prednisone Generic | 128 | 128 | 74 | $215 |
| Roflumilast Generic | 127 | 141 | 19 | $8,767 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 104 | 115 | 19 | $52K |
| Rifampin Generic | 104 | 104 | 20 | $2,674 |
Brand drugs: 3,226 claims; generic drugs: 2,505 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Kyungmee Kim $4,295 ($4,295 in general payments such as food, travel and fees) from 19 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $1,648.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 33 | $1,648 |
| GlaxoSmithKline, LLC. GSK | 24 | $572 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $397 |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $346 |
| Amgen Inc. AMGN | 7 | $279 |
| Abbvie Inc. ABBV | 5 | $208 |
| Daiichi Sankyo Inc. 4568.T | 6 | $160 |
| Electromed, Inc. ELMD | 14 | $141 |
| Merck Sharp & Dohme LLC MRK | 1 | $122 |
| Insmed, Inc. INSM | 4 | $92.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.